Komori
Alfresa Holdings (2784) · FactFirst stated

3.7% Growth in the FY2020-Q3 Prescription Drug Market

First written in FY2020-Q3. . Latest entry: FY2020-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Growth of the Prescription Pharmaceutical MarketA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2020-Q3First statedAnnual report

    「医療用医薬品市場におきましては、抗悪性腫瘍薬の需要拡大等の影響により、市場は3.7％の成長となりました(クレコンリサーチ＆コンサルティング株式会社推定)。」

    FY2020-Q3累計の医療用医薬品市場は、抗悪性腫瘍薬の需要拡大等により3.7％成長したと推定されている。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.